Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Chad Green

2023-24 Player Option/Opt-Out Update: April Edition

By | at

Not long ago, any given year in Major League Baseball might have seen a handful of players have player options to decide upon at the end of a season. Opt-out clauses have slowly worked their way into normalcy among contract negotiations, however, and what was once a perk typically reserved for star players has become more commonly used as a means of either sealing a deal with mid-range free agents or in many instances, gaming the luxury tax. Player options are considered guaranteed money, after all, so it’s become common for clubs on the precipice of luxury penalization to negotiate complex player options that tamp down a contract’s average annual value even though they’re unlikely to ever be exercised.

For the purposes of this look around the league, there’s little sense in separating opt-outs from player options. The two are effectively the same, though “opt-out” typically refers to an out clause where there are multiple years remaining on the contract and “player option” generally refers to an individual decision on the forthcoming season. Both are considered guaranteed money for luxury purposes, and both ultimately come down to the player’s preference, risk tolerance, etc.

At their core, opt-out provisions aren’t particularly different from the much longer-accepted club options that teams have negotiated for years. Teams guarantee a certain number of dollars over a certain number of years, and if the player continues performing at a high enough level, they’ll exercise a club option that’s typically locked in at a below-market price. If not, the player will be bought out and sent back to free agency. Player options and opt-outs are merely the inverse; the player/agent negotiate a certain length and annual value but reserve the right to opt back into the market if the player continues to perform at a high level. It’s two sides of the same coin.

There are more players with the opportunity to opt out of their contract this offseason, by way of a one-year player option or a multi-year opt-out, than ever before. As such, we’ll be keeping tabs on these situations throughout the season. Short of a major injury, performance this early in the season isn’t likely to have a major impact on a player’s likelihood of opting out or forgoing that right, but it’s worth listing out which players will have the opportunity, what their contracts look like, and at least taking an early glance at how they’re performing.

Note: All stats through play on Tuesday.

Position Players

  • Tucker Barnhart, C, Cubs ($3.25MM player option): Barnhart’s deal was announced as a two-year, $6.5MM contract, though he also obtained the right to opt out after 2023, effectively rendering 2024 a player option. He’s 5-for-16 with a walk and four strikeouts through just 17 plate appearances as the backup to Yan Gomes. Barnhart got this guarantee on the heels of a dismal .221/.287/.267 showing with the Tigers in 2022, so with even a decent season he’ll have reason to opt out and try his luck again amid a thin group of free-agent catchers.
  • Josh Bell, 1B/DH, Guardians ($16.5MM player option): Bell limped to the finish line with the Padres after being traded over from the Nationals alongside Juan Soto in last summer’s blockbuster, and he hasn’t yet found his footing in 76 plate appearances with the Guardians. It’s a small sample, but Bell’s .203/.316/.344 slash looks quite similar to the .192/.316/.271 he mustered with San Diego in 2022. Bell hit 37 homers in 2019 and 27 in 2021, but he hits the ball on the ground far too often for someone with his power and lack of speed. Only one qualified hitter in MLB (Masataka Yoshida) has a higher ground-ball rate than Bell’s staggering 66.7% mark.
  • Trey Mancini, 1B/OF, Cubs ($7MM player option, if he reaches 350 plate appearances): Like Bell, Mancini saw his offensive production crater following a deadline trade (to the Astros) last summer and has not yet recovered in a new setting. Through 60 plate appearances, he’s hitting just .196/.220/.250. While his contract is a two-year, $14MM deal, Mancini can opt out if he reaches 350 plate appearances (i.e., the second year becomes a player option). He isn’t hitting yet, but Mancini is playing regularly and appears to be trending toward earning that right.
  • Javier Baez, SS, Tigers (can opt out of remaining four years, $98MM): After turning in a tepid .238/.278/.393 batting line in 590 plate appearances during his first season as a Tiger, Baez would need quite the season to walk away from this kind of cash. So far, he’s hitting .193/.254/.246 in 64 trips to the plate, however. When Baez gets hot, he can go on hot streaks for the ages, but he certainly doesn’t look like he’ll be opting out at season’s end.
  • Justin Turner, 3B/DH, Red Sox ($13.4MM player option): Turner hasn’t found his power yet in Boston, but he’s out to a .277/.385/.385 start with nearly as many walks as strikeouts. His $13.4MM player option comes with a hefty $6.7MM buyout. He’ll turn 39 in November, but as long as he hits reasonably well, he should have more earning power than that $6.7MM net decision.
  • Jorge Soler, OF/DH, Marlins ($9MM player option): Soler’s three-year, $36MM deal in Miami pays him $12MM in 2022, $15MM in 2023 and $9MM in 2024, but he had the right to opt out after each season of the deal. He hit just .207/.295/.400 with 13 homers in 306 plate appearances last year, so there was no way he was taking the first opt-out. He’s already clubbed five dingers in 62 plate appearances in 2023. His .263/.323/.649 slash translates to a 155 wRC+, and his exit velocity and hard-hit rate are through the roof, so his .256 average on balls in play should at least hold steady. Soler is an extremely streaky hitter, so time will tell how much of this early heater he can sustain, but there’s plenty to like about his start, including a reduced strikeout rate.
  • Michael Conforto, OF, Giants ($18MM player option, if he reaches 350 plate appearances): As with Mancini, Conforto is on a two-year deal but gains the right to opt out after one year if he reaches 350 plate appearances. You can call it an opt-out or a player option, but it’s the same mechanism; if Conforto is healthy, he’ll likely get the right to opt out. So far, he’s hitting .220/.373/.439 with a trio of homers in 51 trips to the plate. Conforto has walked nine times in those 51 plate appearances (17.6%), and his chase rate is actually down, so he still has good knowledge of the zone. However, a year-long layoff due to shoulder surgery is perhaps making itself known with a 74.5% contact rate on pitches in the strike zone, as that’s nearly 10 percentage points below his career mark of 84%. Unsurprisingly, Conforto’s 31.4% strikeout rate is a career worst. Some rust was inevitable, though, and the plate discipline and hard contact when he has made contact (94.4 mph exit velo, 52.5% hard-hit rate) are encouraging.
  • Matt Carpenter, 1B/DH, Padres ($5.5MM player option): Carpenter’s stunning return with the Yankees last year was one of the best stories of the summer, but he’s out to a sluggish .152/.317/.273 start with the Padres. He’s chasing off the plate at a 30.3% clip after doing so at a 20.7% rate last summer, and his contact rate on swings off the plate has plummeted from 62.5% to 36.4%. It’s a small sample and there’s time to turn things around, of course, but he’s had a tough start.

Pitchers

  • Andrew Heaney, LHP, Dodgers ($13MM player option): Heaney’s first Rangers start was one to forget (seven earned runs), but his second start was dominant, as he tied an AL record by fanning nine consecutive hitters. If Heaney tops 150 innings and doesn’t finish the year with an injury that’d likely keep him out for the first 60-plus innings of the 2024 season, the value of that player option jumps to $20MM. He hasn’t reached 150 innings since 2018.
  • Seth Lugo, RHP, Padres ($7.5MM player option): Lugo’s return to the rotation has been solid. He’s posted a 2.70 ERA through 16 2/3 frames with strikeout and walk ratios that look similar to his numbers out of the bullpen (24.3% strikeout rate, 7.1% walk rate). It’s anyone’s guess how many innings Lugo will tally after throwing just 228 innings combined from 2019-22, when he was primarily a reliever, but a solid run out of the rotation will position him to turn down that player option in search of a multi-year deal in free agency.
  • Sean Manaea, LHP, Giants ($12.5MM player option): The early ERA isn’t much to look at (4.76 in 11 1/3 innings), but the Giants have Manaea averaging 94.7 mph on his four-seamer. That’s a career-high by a wide margin, as he sat 91.7 mph on a now-scrapped sinker in 2021-22 and 91.1 mph on his four-seamer in 2017-20. Any major velocity gain of this nature is worth keeping an eye on.
  • Nick Martinez, RHP, Padres (team has two-year, $32MM club option; if declined, Martinez has two-year, $16MM player option): Martinez’s strikeout rate, walk rate, home-run rate and velocity have all gone the wrong direction through his first three starts. It’s just 17 2/3 innings, so it could be rendered a footnote if he rebounds and the Padres pick up their hefty option on the righty. Still, it’s not the start he or the Padres wanted.
  • Eduardo Rodriguez, LHP, Tigers (can opt out remaining three years, $49MM): E-Rod hasn’t missed bats anywhere near his Boston levels since signing with the Tigers. The lefty still showed good command both in 2022 and so far in 2023, but his 8.7% swinging-strike rate and 20.4% strikeout rate are well shy of the respective 11.6% and 26% marks he posted in his final four years with the Red Sox. Rodriguez’s velocity in 2023 is back up after a slight dip in 2022, but if he can’t get back to missing bats at his prior levels it’ll be an easy call for him to forego that opt-out provision.
  • Max Scherzer, RHP, Mets ($43.333MM player option): Scherzer hasn’t gotten out to his best start, but he posted a 2.29 ERA with gaudy strikeout and walk rates (30.6% and 4.2%) in 145 1/3 frames with the Mets in 2022. He was at the center of controversy after being ejected from today’s start after failing a foreign substance check, though that’s not likely to have any effect on his opt-out decision. Scherzer has already suggested that his opt-out was negotiated in part to ensure that he’d have an opportunity to look elsewhere if the Mets didn’t remain fully committed to winning. That hasn’t been the case under owner Steve Cohen, who’s currently financing the largest payroll and luxury-tax bill in MLB history.
  • Ross Stripling, RHP, Giants ($12.5MM player option): Stripling has been ambushed for 10 runs in his first 12 1/3 innings of work and had been set to operate primarily out of the bullpen before the injury to Alex Wood. It’s not a great start considering the weighty $25MM guarantee on his deal, but he has time to turn things around. A stunning six of the 13 fly-balls Stripling has yielded in 2023 have cleared the fence for a home run, and that rate will surely stabilize over a larger sample. Still, if he’s relegated to long-relief duty for too long, it’ll become difficult for him to even consider his opt-out.
  • Marcus Stroman, RHP, Cubs ($21MM player option): Stroman took a rather atypical contract structure for a 31-year-old free agent, inking a three-year guarantee at a premium annual value with an opt-out after year two. It’s more common to see pitchers that age push for the longest deal possible, but it might work out in Stroman’s favor. He’ll bank $50MM through the contract’s first two seasons, and after a nice 2022 season (3.50 ERA, 3.74 SIERA in 138 2/3 innings), he’s come roaring out of the gates with a 0.75 ERA and vastly improved 26.9% strikeout rate through his first 24 frames. Stroman’s walk rate is also up, and it’s all a small sample for now anyway, but it’s a promising start all the same. He’ll turn 33 in 2024, and if he continues anywhere near the pace he’s set since 2019 (3.15  ERA in 520 innings), he should have no problem topping that $21MM in free agency. He’ll also be ineligible for a qualifying offer, having already received one earlier in his career.
  • Michael Wacha, RHP, Padres (two-year, $32MM club option; if declined, Wacha has $6.5MM player option and $6MM player options in 2025-26): Wacha’s four-year, $26MM deal was effectively just the Padres manipulating the luxury tax by meeting Wacha’s price tag on a multi-year deal but spreading out the term to tamp down the AAV. Wacha’s total guarantee is the type of money one might’ve expected him to land over a two- or perhaps three-year term. By spreading it to four, the Padres could end up avoiding the third luxury-tax bracket. Wacha has a 6.06 ERA through three starts and posted an ERA of 4.76 or worse each season from 2019-21. If he can wind up replicating his strong 2022 results, the Padres might consider picking up their end of the option, but the likelier scenario is that they decline, leaving Wacha with a remaining three years and $19MM, but opt-outs after each season.
  • Chad Green, RHP, Blue Jays (three-year, $27MM club option; if declined, Green has $6.25MM player option; if both decline, team has two-year, $21MM option): Green may have the most convoluted contract of the entire free-agent class. That’s reflective both of his considerable talent and the broad range of outcomes as he works back from last May’s Tommy John surgery. We won’t know have an inkling of how this’ll play out until at least the summer, as Green needs to finish off his rehab. If he can return to peak form (1.83 ERA, 40.7% strikeout rate, 6.7% walk rate) for three or so months down the stretch, perhaps the Jays would actually consider the three-year, $27MM option. But that’s premium setup man money, and Green will be coming back from a year-long absence with a major surgery on his recent resume. He’ll have a $6.25MM player option if that three-year team option is declined, and that seems far more plausible. The two-year, $21MM option if both parties decline their first options feels only slightly more viable than the Jays’ original 3/27 decision.

Blue Jays Re-Sign Jay Jackson

By | at

March 29: The Blue Jays announced the signing of Jackson to a one-year, Major League contract. He will indeed head to Triple-A Buffalo for now. Righty Chad Green, who’s still on the mend from Tommy John surgery, was moved to the 60-day injured list to open a spot on the 40-man roster.

March 28: The Blue Jays and righty Jay Jackson have agreed to a new split contract following the reliever’s release a few days ago, reports Arden Zwelling of Sportsnet (Twitter thread). Jackson, a client of Nello Gamberdino, will earn a $1.5MM salary at the MLB level.

The 35-year-old Jackson originally inked a minor league deal with the Jays over the winter. He enjoyed a strong spring, yielding only a pair of unearned runs on seven hits and two walks while punching out 13 hitters over the course of 9 1/3 frames.

That excellent spring effort in many ways marked a continuation of a strong run that Jackson enjoyed with the Braves organization in 2022. He tossed just 1 1/3 scoreless innings with the big league club in Atlanta, though his lack of opportunity was largely due to a stacked MLB bullpen. Jackson posted a 2.29 ERA with a 31.3% strikeout rate and 5% walk rate in 19 Triple-A appearances as well.

Jackson spent the 2021 season with the Giants organization, pitching to a 3.74 ERA with a 31.1% strikeout rate and 13.3% walk rate in 21 2/3 big league innings. He’s also spent parts of four seasons in Japan, split between the Hiroshima Carp and Chiba Lotte Marines, with a combined 2.16 ERA, 27.4% strikeout rate and 9.5% walk rate in 183 innings there. It’s far from a typical career arc, but Jackson has had plenty of success from his late 20s into his mid-30s, and he could get a chance to continue that trend with the Blue Jays before long.

Players That Could Move To The 60-Day IL Once Spring Training Begins

By | at

Just about every baseball team has a full 40-man roster now, with the Astros the only team with an open spot at the moment. That means that just about every transaction, be it a free agent signing or a waiver claim, requires a corresponding move.

However, that could soon change as the injured list is coming back soon. There’s no IL from the end of a season until pitchers and catchers report to Spring Training for the next campaign, which they will do next week. That means some clubs could potentially gain a bit of extra roster flexibility at that time, since players on the 60-day IL don’t count against a team’s roster total. However, it’s worth pointing out that the “60 days” don’t start until Opening Day, which is March 30 this year. That means, though a team can transfer a player to the 60-day IL next week, they will likely only do so if they aren’t expecting the player back until end of May or later.

With some notable free agents still unsigned like Jurickson Profar, Andrew Chafin, Michael Wacha, Elvis Andrus and many others, it’s possible that teams interested in their services might try to hold off on getting a deal done until next week. Or perhaps clubs that have players they would like to sneak through waivers will try to do so now, before rival clubs gain that extra roster flexibility with the IL opening up. Then again, some clubs will need to keep in mind non-roster players they are planning to promote by Opening Day and might hold off on making a move until that time.

Here are some players who are expected to miss some significant time and could find themselves transferred soon, sorted by division.

AL East

Hyun Jin Ryu/Chad Green

The Blue Jays have a pair of pitchers on their 40-man roster who are returning from Tommy John surgery. They should be on a similar timeline, as they each underwent the procedure in June of last year, though Green will most likely return first since relievers generally require less time to build up arm strength compared to starters. Regardless, the recovery time period for TJS is about 12-18 months, meaning neither pitcher is likely to return until midseason at the earliest. Ryu recently said he was targeting a July return.

Trevor Story

The Red Sox shortstop recently underwent an internal brace procedure on his throwing elbow, a similar operation to Tommy John. Though he’s confident he’ll return at some point, he’s slated to miss most of the upcoming season and is certainly headed for the injured list.

John Means

The Orioles lefty underwent Tommy John surgery in late of April of 2022. With the 12-18 month recovery window for TJS, he could theoretically return in the first couple of months of the season, so the O’s may not want to transfer him to the injured list until they have some clarity about his timeline.

Scott Effross/Luis Gil/Frankie Montas

Effross is a lock for the Yankees’ injured list as he underwent Tommy John in October and will likely miss the entire 2023 campaign. Gil had the same surgery but in May, which means he’ll likely be out until midseason. The situation with Montas is a bit less clear, as he’s dealing with shoulder inflammation that is expected to keep him out for the first month of the season. Unless he suffers some sort of setback, he probably won’t be placed on the 60-day IL right away.

Shane Baz/Andrew Kittredge

The Rays have a couple of hurlers bound for the IL as Baz underwent Tommy John in September while Kittredge had the same surgery in June. They’re both going to miss the first half of the year, with Baz potentially missing the entire season.

AL Central

Casey Mize/Tarik Skubal

Mize underwent Tommy John surgery in June and should be placed on the Tigers’ IL at some point. Skubal’s case is a bit less certain after he underwent flexor tendon surgery in August. The club hasn’t provided a timeline for his recovery but some recent comparables can give us some idea. Danny Duffy underwent the procedure in October of 2021 and was hoping to return by June of 2022, though a setback prevented him from pitching at all on the year. Matthew Boyd went under the knife for flexor tendon surgery in September of 2021 and didn’t return to a big league mound until September of 2022.

Garrett Crochet/Liam Hendriks

Crochet of the White Sox underwent Tommy John surgery in April of last year but was already stretched out to throwing from 120 feet in November. Whether he’s able to return in the early parts of 2023 or not will depend on his continued progression in that recovery process. In a less conventional situation, Liam Hendriks announced last month that he’s beginning treatment for non-Hodgkin’s lymphoma. It’s unknown how long his treatment will take but general manager Rick Hahn said they don’t expect updates “prior to Opening Day at the very earliest.”

Chris Paddack/Royce Lewis

Paddack was recently extended by the Twins though he underwent Tommy John in May of last year and likely won’t be ready to return until the middle of the upcoming campaign. Lewis tore the anterior cruciate ligament in his right knee in June of last year, the second year in a row that he suffered that unfortunate injury. At the time, his recovery timeline was estimated at 12 months, which likely puts him on the shelf until midseason as well.

AL West

Brett Martin

It was reported last month that the Rangers lefty will require shoulder surgery. It was said that the timeline will become more clear in the aftermath of the procedure but he’s likely to miss the entirety of the upcoming season.

NL East

Bryce Harper

The Phillies superstar underwent Tommy John surgery in November and the club has announced they expect him to be out of action until around the All-Star break in July.

Huascar Ynoa/Tyler Matzek

Both these Braves pitchers underwent Tommy John last year, with Ynoa going under the knife in September and Matzek in October. That makes them both long shots for appearing at all this year, but especially not in the first half.

Max Meyer/Anthony Bender/Sixto Sanchez

The Marlins have a couple of arms that will certainly miss time this year and one more that’s a wild card. Meyer and Bender both underwent Tommy John in August and will miss most of the upcoming campaign. Sanchez underwent arthroscopic shoulder surgery in October with the club announcing at that time they expected him back by spring. It was reported last month that Sanchez is already throwing bullpens, which perhaps points against an IL stint. However, after the shoulder issues completely wiped out his 2021 and 2022 seasons, it’s hard to know how much to rely on his health going forward.

Danny Mendick

The Mets signed Mendick after he was non-tendered by the White Sox. The infielder/outfielder tore the anterior cruciate ligament in his right knee in June of last year and missed the second half of the season. There haven’t been any updates on his status recently, but further clarity will likely come when camp gets rolling.

Tanner Rainey/Stephen Strasburg

The Nationals have one fairly straightforward case in Tanner Rainey, who underwent Tommy John in August and will likely miss most of the upcoming season. What’s less clear is the situation surrounding Strasburg, who’s hardly pitched at all over the past three years due to thoracic outlet syndrome and various issues seemingly related to that. He made one appearance in the big leagues last year, pitching 4 2/3 in one start in June but went on the IL right after and never returned. He spoke about the issue in September, saying he hadn’t thrown in months and that he is “not really sure what the future holds.”

NL Central

Ethan Roberts/Codi Heuer/Kyle Hendricks

Roberts underwent Tommy John in June and likely won’t be available for the Cubs until midseason. Heuer had TJS in March but the latest reporting suggests he won’t return until June or July. The status of Hendricks is less clear, with the righty trying to recover from a capsular tear in his shoulder. The club is hoping to have him back by Opening Day but also said they won’t rush him. He recently said that he’s expecting to be on a mound by March 1.

Vladimir Gutierrez/Tejay Antone

Gutierrez, a Reds righty, underwent Tommy John in July and should miss the first few months of the upcoming season at least. Antone was rehabbing from a Tommy John of his own when he suffered a flexor strain in his forearm. He announced today he’s received a platelet-rich plasma injection to treat the issue and suggested he might miss the first half of the season.

Max Kranick

The Pirates right-hander required Tommy John in June and will miss the first half of the upcoming campaign.

NL West

Antonio Senzatela/Tyler Kinley

The Rockies have a couple of murky situations on their hands with these hurlers. Senzatela tore the anterior cruciate ligament in his left knee last year and required surgery in August. The timeline at that point was given at 6-8 months, which would place his return somewhere in the February-April window. Whether he’ll require a lengthy IL stint will depend on if his recovery is still on that track. Kinley was diagnosed with an elbow strain and a flexor tear in his forearm in June of last year. He underwent surgery in July with the club announcing they expected him to miss one calendar year, which should prevent him from pitching early in the campaign.

Walker Buehler/Blake Treinen/J.P. Feyereisen

The Dodgers have a trio of pitchers that are likely to miss most or perhaps all of the upcoming season. Buehler required Tommy John in August and could potentially return very late in the year. Treinen underwent shoulder surgery in November with an estimated recovery time of 10 months. Feyereisen underwent shoulder surgery in December and won’t be able to begin throwing until four months after that procedure, or around April. His eventual return to game shape will depend on how long it takes him to progress from simply throwing to getting up to full game speed.

Luke Jackson

The Giants signed the right-hander in free agency, despite Jackson undergoing Tommy John in April. President of baseball operations Farhan Zaidi told reporters last month that there was a chance Jackson begins the year on the 60-day IL, though that doesn’t seem to indicate any kind of setback. “He’s doing great in his rehab, so we’re going to wait and see how he’s doing in spring training,” Zaidi said.

Blue Jays Sign Chad Green

By | at

The Blue Jays have signed right-hander Chad Green to a deal that will reportedly guarantee him $8.5MM over two years. He will make $2.25MM in 2023 and then Jays will then have the option of triggering a $27MM option for the next three years, with up to $1MM in bonuses. If they decline, Green’s player option for 2024 will be for $6.25MM with $2MM in bonuses. If he declines that, the Jays can trigger a two-year, $21MM option with $1MM in bonuses. Since player options are considered guaranteed, the $8.5MM figure comes from the 2023 salary and 2024 player option. Green is a Frontline client.

Green, 32 in May, has been serving as a quality reliever for the Yankees for the past seven seasons but was sidelined in May of last year and underwent Tommy John surgery shortly thereafter. This deal provides both parties with a bit security for the future. If Green comes back healthy and looks like his old self, the Jays can get some long-term value out of their investment by keeping him around for future seasons. If Green should suffer some kind of setback or struggle to get back on track in his return, he will at least be able to lock in some salary for 2024.

An 11th round draft pick of the Tigers in 2013, Green and Luis Cessa went to the Yankees in the December 2015 trade that sent Justin Wilson to Detroit. He was primarily a starter at that time and made his MLB debut in 2016 in a swing capacity. That was essentially the end of his time as a true starter, as the Yanks converted him to relief on a full-time basis. He did make one start in 2017 and 15 in 2019, but those were of the “opener” variety, none of them longer than two innings.

Since making that transition, he has somewhat quietly been one of the most effective relievers in the league. Over the past six major league seasons, he’s pitched 338 innings over 260 total appearances with a 2.96 ERA, striking out 33.4% of batters faced while walking just 6.1%. Among relievers to throw over 300 innings in that stretch, he ranks fourth in strikeout rate, trailing only elite guys Josh Hader, Edwin Díaz and Liam Hendriks and coming in ahead of Kenley Jansen and Ryan Pressly. Green was never given the closer’s role due to the presence of Aroldis Chapman, tallying just 11 saves in his career so far, but he does have 52 holds.

The Tommy John surgery was quite poorly timed for Green, as he was just a few months away from qualifying for free agency. He would have been one of the top relievers this offseason if not for that. However, if he can return to the mound and post results similar to those already on his track record, he’ll still wind up with a nice payday. After making $2.25MM this year, if he Jays pick up that three-year option, he’ll get to $29.25MM in earnings. That’ll be just a bit shy of some other deals for notable relievers this offseason, such as the $32MM for Jansen, $33MM for Taylor Rogers and $34.5MM for Rafael Montero.

For the Jays, this won’t affect their bullpen immediately but it will potentially give them a boost at some point later this year. They will likely have Jordan Romano in the closer’s role, with other high-leverage jobs going to pitchers like Yimi García, Erik Swanson, Anthony Bass and Tim Mayza. Once Green is able to return, he will jump into the mix with that group. The Jays will now have two pitchers potentially bolstering their staff midway through the upcoming campaign, as Hyun Jin Ryu also underwent TJS last year and is targeting a return around the All-Star break.

Financially, this nudges the Jays slightly farther into luxury tax territory. Roster Resource now pegs their competitive balance tax figure at $246MM, about $13MM beyond the $233MM threshold. As a first-time payor in the lowest tax bracket, the club is subject to a 20% tax on its overages, currently just over $2.5MM.

Michael Marino of Fantrax first reported the Jays and Green were in agreement. Shi Davidi of Sportsnet for had the $8.5MM guarantee and presence of options for 2025 and 2026, as well as later adding the breakdown of the options (Twitter links). Ken Rosenthal of The Athletic first added the complex option framework and that Green passed his physical (Twitter links).

Blue Jays Designate Matt Gage For Assignment

By | at

The Blue Jays have designated reliever Matt Gage for assignment, the club announced. The move opens a 40-man roster spot for Chad Green, who has officially signed his two-year deal.

Gage, 30 next month, played eight seasons in the minor leagues after entering the professional ranks as a 10th-round pick of the Giants in 2014. Signed to a minor league contract by the Jays last offseason, the Siena product had a breakout year for Triple-A Buffalo. He worked to a 2.34 ERA over 42 1/3 innings of relief for the Bisons, striking out 27.4% of opponents with a 47% grounder rate. Gage’s 9.5% walk percentage was the only yellow flag, though that was just a hair north of average.

That production earned him his first major league call last June. He got into 11 MLB games, working 13 innings of four-run ball. Gage induced grounders on half the batted balls he allowed. The 6’3″ hurler had a modest 12:6 strikeout-to-walk ratio in his limited big league time but induced swinging strikes on over 14% of his pitches. He relied on a low-90s four-seam and a mid-80s cutter during his big league work.

Gage held left-handed hitters to a laughable .086/.149/.111 line in 88 Triple-A plate appearances last year. Righties hit .271 with a .363 on-base percentage but only mustered a .355 slugging mark. That could appeal to clubs looking to stockpile left-handed relief depth. Gage has two minor league option years remaining, so any team willing to keep him on the 40-man roster could stash him in Triple-A for the foreseeable future. The Jays will have a week to deal him or look to run him through waivers.

Post-Tommy John Players That Could Impact 2023

By | at

News items about Tommy John surgeries are fairly commonplace in baseball circles, but there’s no doubting it’s a significant event for the impacted player. It usually takes over a year to return to form, with a multi-stage rehabilitation process required to regain functionality.

Once a player gets back into game shape, there’s no guarantee the results will be the same. Justin Verlander looked just as good as ever in 2022, but Mike Clevinger didn’t get his velocity all the way back and saw his strikeout rate dip. He could still take another step forward in 2023 now that he’s another year removed from the procedure, but it goes to show that there are no guarantees about what happens in the aftermath.

Here are some players who went under the knife over the past year or so and who will be looking for good progress in 2023, both for their teams and themselves. Huge shoutout to the Tommy John Surgery list for having these details and so much more.

Forrest Whitley, Astros — Surgery Date: March 2021

Whitley, 25, was once considered one of the best pitching prospects in baseball, but his progress has been stalled by various factors. He missed 50 games in 2018 due to a drug suspension, and injuries have hampered him in the years since. He returned from his layoff late last year and tossed 40 innings in the minors but walked 14.5% of batters faced. The Astros already have a great rotation without him, but if Whitley could get back to the form that made him such a hyped prospect, they would be even more loaded.

Kirby Yates, Braves — March 2021

Yates, 36 in March, was one of the best relievers in the league in 2018 and 2019, arguably the best. He posted a 1.67 ERA over 125 games, striking out 38.7% of batters faced, walking just 6.1% of them and getting grounders on 45.2% of balls in play. Since then, however, he’s thrown just 11 1/3 innings. Seven of those came late in the 2022  season, though Yates gave up four runs on six hits and five walks in seven innings. This will be his first full season back. The Braves have a strong bullpen even if Yates can’t get back to peak form, but they’ll likely be in a tight division race and that kind of elite stuff would provide a nice boost.

José Leclerc and Jonathan Hernández, Rangers — March and April 2021, respectively

Leclerc, 29, seemed to be establishing himself as an excellent reliever in 2018. He got into 59 games for the Rangers and posted a 1.56 ERA, getting 12 saves and 15 holds in the process. A .211 BABIP surely helped, but there was a lot to like. He took a step back in 2019 with a 4.33 ERA and then missed most of the following two years. Leclerc returned in June of last year and struggled at first before posting a 2.01 ERA from July onwards. Hernández had a 2.90 ERA in 2020 before missing the 2021 campaign. He returned last year and posted a 2.97 ERA, but with concerning peripherals. His 6.4% walk rate from the former campaign jumped to 13% while his strikeout rate fell from 24.8% to 20.6%. On the more encouraging side, his ground ball rate went from 45.7% to 62.4%. The Rangers totally overhauled their rotation without doing much to the bullpen, but they could potentially get a boost from within if Leclerc and/or Hernández look good this year.

Adrián Morejón, Padres — April 2021

Once considered a top pitching prospect, Morejón, 24 next month, has been slowed by various injuries. He returned in 2022 but worked only in relief, tossing 34 innings in the majors and 13 1/3 in the minors. The Padres have some uncertainty in the back of their rotation that Morejón could help with if he stays healthy, but he’ll likely have workload concerns after so much missed time.

James Paxton, Red Sox — April 2021

Paxton, 34, had a great four-year run with the Mariners and Yankees from 2016 to 2019. However, he’s hardly pitched over the last three years due to various arm issues. He got back on the mound last summer while attempting to come back from Tommy John but then suffered a lat tear that halted his comeback effort. The Red Sox then had the choice to trigger a two-year option on the lefty worth $26MM, which they turned down based on his uncertain health outlook. He then had a $4MM player option that he triggered and will be with the Sox for 2023. He and Chris Sale would have made for a formidable one-two punch at the top of a rotation a few years ago, but neither has been healthy and effective for quite some time. Their status this year figures to have a huge impact on the fortunes of the Sox for the upcoming campaign.

Dustin May, Dodgers — May 2021

May, 25, returned late last year and was able to make six starts for the Dodgers. He posted a 4.50 ERA in that time and struck out 22.8% of batters faced, with both of those numbers paling in comparison to his pre-surgery form. The Dodgers let Tyler Anderson and Andrew Heaney depart from their 2022 rotation, while bringing in Noah Syndergaard. The quiet offseason will be easier to accept if May can post results like he did over 2019-2021: 2.93 ERA, 24.2% strikeout rate, 5.9% walk rate, 51.6% ground ball rate.

Joey Lucchesi, Mets — June 2021

Lucchesi, 30 in June, made 56 starts for the Padres in 2018 and 2019 with a 4.14 ERA. He didn’t get much of an opportunity in 2020 and was flipped to the Mets as part of the Joe Musgrove trade. He isn’t one of the club’s five best starters right now, but their rotation features four veterans who are 34 or older in Verlander, Max Scherzer, Carlos Carrasco and José Quintana. Also, Kodai Senga is making the transition from Japan, where starters frequently only pitch once a week. The club will surely need to rely on its depth this year at some point, making Lucchesi a key part of the equation.

Spencer Turnbull, Tigers — July 2021

Turnbull, 30, was seeming to make progress towards being a quality starter for the Tigers. He posted a 4.61 ERA in 2019 but got that down to 3.97 in 2020. He pushed it down even more in 2021, registering a 2.88 ERA over nine starts before getting shut down and requiring surgery. The Tigers seem likely to be without Casey Mize and Tarik Skubal to start the year as those pitchers deal with their own injuries. That could leave a path for Turnbull to get back on track.

Tyler Glasnow, Rays — August 2021

Glasnow, 29, didn’t live up to expectations with the Pirates but made good on his prospect pedigree after getting traded to the Rays. From 2019 to 2021, he had a 2.80 ERA while striking out 35.9% of batters faced and walking just 7.8% of them. Tommy John surgery put him out of action for a while but he was able to return late last year, making two starts in the regular season and one in the postseason. Glasnow has looked like an ace at times but still hasn’t maintained it over an extended stretch, still never reaching 115 innings in a major league season. The Rays have been fairly quiet this winter, but a healthy Glasnow is arguably a bigger upgrade to their roster than any move they could have made.

Tejay Antone, Reds — August 2021

Antone, 29, debuted in 2020 and was excellent out of the Reds’ bullpen. Over that year and 2021, he tossed 69 innings with a 2.48 ERA, 32.3% strikeout rate and 48% ground ball rate. The walks were a little high at 10.8% but he was still able to be incredibly effective regardless. He isn’t slated to reach free agency until after 2025, but the rebuilding Reds might have to consider a deadline deal if Antone is healthy and pitching well this summer.

Garrett Crochet, White Sox — April 2022

Crochet, 24 in June, was selected 11th overall in the 2020 draft and made his MLB debut later that year. Between his five appearances in 2020 and 54 more the following year, he has a 2.54 ERA and 29% strikeout rate. He’ll likely miss at least part of the upcoming campaign but the club is planning on keeping him in a relief role, which could help him return quicker.

Luke Jackson, Giants — April 2022

Jackson, 31, had a huge breakout with the Braves in 2021. He tossed 63 2/3 innings with a 1.98 ERA, striking out 26.8% of batters faced while getting grounders at a healthy 52.5% clip. He wasn’t as effective in the playoffs but nonetheless was part of the club’s World Series victory that year. He reached free agency and signed with the Giants, who are taking a shot on a return to form, though Jackson might miss the first couple of months of the 2023 season.

John Means, Orioles — April 2022

Means, 30 in April, was one of the few highlights for the Orioles during their leanest rebuilding years. He has a 3.81 ERA in 356 2/3 career innings, keeping his walks down to an excellent 5% rate. The Orioles took a huge step forward last year, graduating many of their top prospects and actually flirting with postseason contention. They’ll be looking to make more progress this year, but the rotation is still lacking in proven options. Getting Means back into the mix would be a big help if some of the younger guys struggle.

Chris Paddack, Twins — May 2022

Paddack, 27, had a great debut with the Padres in 2019, making 26 starts with a 3.33 ERA. His results fell off in the next two seasons, and he dealt with an elbow strain late in the 2021 season, but the Twins still liked him enough to acquire him as part of their return for Taylor Rogers. He was only able to make five starts before landing on the shelf. Their faith doesn’t seem to have wavered, as they recently signed him to a three-year extension. The Twins have a solid rotation on paper, but nearly the entire group landed on the injured list at some point in 2022. Kenta Maeda missed the whole season while rehabbing from an internal brace procedure, a modification of Tommy John surgery. Since injuries were the big story for the Twins in 2022, better health and/or better depth will be important in 2023.

Chad Green, Free Agent — June 2022

Green, 32 in May, spent the past seven seasons pitching for the Yankees. He tossed 383 2/3 innings in that time with a 3.17 ERA, striking out 32.5% of batters faced against a 6.3% walk rate. Unfortunately, he required Tommy John just a few months away from qualifying for free agency. He has yet to sign with a club, but players in this position often sign two-year deals that cover their rehab and give the team an extra year of control. If Green can find himself a deal like that, he could be a wild card down the stretch.

Casey Mize, Tigers — June 2022

Mize, 26 in May, was selected first overall by the Tigers in 2018. He posted a solid 3.71 ERA in 2021, but with disappointing underlying metrics. He only struck out 19.3% of batters faced and had a much higher 4.92 xERA, 4.71 FIP and 4.45 SIERA. After a dreadful 2022 season, the Tigers need to see how Turnbull, Mize, Skubal and Manning look this year before deciding how to proceed for the future.

Hyun Jin Ryu, Blue Jays — June 2022

Ryu, 36 in March, has oscillated between being injured and dominant for much of his career. He signed a four-year deal with the Blue Jays prior to 2020 and posted a 2.69 ERA that year, coming in third in the AL Cy Young voting. His ERA ticked up to 4.37 in 2021, and Ryu struggled even more last year before going under the knife. The Jays have a solid front four in their rotation but uncertainty at the back. Ryu is targeting a July return, and his health at that time could impact how the Jays approach the trade deadline.

Andrew Kittredge, Rays — June 2022

Kittredge, 33 in March, dominated in 2021 by posting a 1.88 ERA over 71 2/3 innings. He struck out 27.3% of batters he faced while walking just 5.3% of them and also got grounders on 53.5% of balls in play. He took a step back last year but made multiple trips to the injured list and likely wasn’t 100%. He’ll surely miss the first several months of the season but could jump into Tampa’s bullpen down the stretch.

Walker Buehler, Dodgers — August 2022

Buehler, 28, has an excellent track record for the Dodgers, having posted a 3.02 ERA in 638 1/3 innings. He’s struck out 27% of opponents while giving out free passes to just 6.3% of them. The Dodgers will have to get by without him for the majority of 2023, though there’s a chance he could be a late addition to the roster if all goes well. His August surgery makes him roughly one year behind Glasnow, who was able to return late in 2022. However, Glasnow’s procedure was August 4th of 2021 while Buehler’s was on the 23rd of last year. Still, if the Dodgers make a deep postseason run, that could give Buehler the runway he needs to make a landing this year.

September 2022 Or Later: Shane Baz, Anthony Gose, Scott Effross, Tyler Matzek, Bryce Harper

These players face longer odds of making an impact since their surgeries were so late in the year. The major exception is Harper, since position players require less recovery time than pitchers. Harper is hoped to be able to return to the Phillies around the All-Star break as a designated hitter, with a chance of returning to the field later in the campaign.

Yankees Place Josh Donaldson On IL With Shoulder Inflammation

By | at

The Yankees announced today that third baseman Josh Donaldson has been transferred from the COVID-19 Injured List to the 10-day injured list, retroactive to May 24, due to right shoulder inflammation. While he was on the COVID IL, he wasn’t counting against the team’s 40-man roster, meaning a corresponding move was required in that department, which the club announced as Chad Green being transferred to the 60-day IL.

The news is surely something of a disappointment for the Yankees and their fans. Donaldson, 36, had been on the COVID list for the past few days due to experiencing symptoms. But since he continued to test negative, it seemed possible that he could make a quick return once those symptoms abated. Now it seems he will be out for at least another week due to this shoulder issue. This isn’t the first time that Donaldson has been held back by shoulder inflammation, as the same injury landed him on the injured list for about two weeks while with the Blue Jays in April 2018.

Acquired from the Twins in an offseason trade, Donaldson’s tenure in the Bronx is off to a good start. Through 37 games, he’s hitting .238/.349/.415 for a wRC+ of 130 as the club is currently sitting on a record of 32-13, the best in baseball. Donaldson’s contributions will now continue to be on hold while he recuperates. Manager Aaron Boone told reporters, including Lindsey Adler of The Athletic, that the injury has been bugging Donaldson for a while. He received a cortisone shot this week with the club hopeful he’s not facing an extended absence.

With Donaldson out of action, the logical backup plan would have been to use DJ LeMahieu at third base, though he’s been dealing with left wrist discomfort and hasn’t appeared in a game since Monday. Adler relays word from Boone that LeMahieu’s condition has improved enough that he could appear in the game at some point tonight, though he isn’t in the starting lineup. Marwin Gonzalez has been getting the starts at the hot corner lately and figures to do so until LeMahieu and/or Donaldson are eligible to return.

The transfer of Green to the 60-day IL is a mere formality, as it was announced earlier this week that he will require Tommy John surgery. That will keep him out of action for the remainder of this year and at least part of next season as well.

Chad Green To Undergo Tommy John Surgery

By | at

Yankees manager Aaron Boone told reporters, including Lindsey Adler of The Athletic, that Chad Green will undergo Tommy John surgery.

The news is not surprising but is nonetheless disappointing. Green left Thursday’s game with forearm discomfort, with Boone relaying that the injury was feared to be significant. The club initially held off on making any declarative statements, though it seemed like a notable surgical procedure was on the table as they collected further medical opinions. Now, unfortunately, the severity of the situation has been agreed upon, with Green headed for the surgery that should keep him out of action for the next 12-18 months.

This is the second blow to the Yankees’ pitching staff in recent days, as it was announced yesterday that Luis Gil is also going under the knife for Tommy John. The club has had remarkable pitching health on the year overall, with their rotation front five of Gerrit Cole, Jordan Montgomery, Jameson Taillon, Luis Severino and Nestor Cortes Jr. making every start for the team, except for a single spot start from Gil. However, these two surgeries are still notable, taking out the club’s sixth starter and a key member of the relief corps.

Green has somewhat quietly been one of the most effective and durable relievers in the game over the past few years, having not been on the IL since 2016, until this week. His 326 relief innings pitched from 2016 to the present are bested by only 21 other pitchers in the league. He hasn’t just been taking mop-up duty either, as he has a 2.79 ERA out of the bullpen in his career, with a 32.8% strikeout rate and 5.9% walk rate, racking up 11 saves and 52 holds.

It’s also very unfortunate for Green personally, as he is set to reach free agency at season’s end. After years of being healthy and productive, suffering a serious injury just months before heading into the open market is incredibly unlucky timing, to state the obvious. He will now head into free agency with teams knowing he won’t be available until the middle of the 2023 campaign, at the earliest. It’s possible he will still garner interest on a back-loaded or incentive-laden contract, such as those recently signed by Ken Giles, Kirby Yates or Tommy Kahnle., who were also working their way back from Tommy John when their contracts were signed.

Yankees Place Chad Green On IL With Elbow Strain

By | at

The Yankees announced today that right-handed reliever Chad Green has been placed on the 15-day injured list with a right elbow strain. Fellow righty Ron Marinaccio has been recalled in a corresponding move.

Green’s move to the IL is hardly surprising, given the events of recent days. He was removed from Friday’s game after a meeting on the mound with the team’s training staff, with clear concern about an injury. Yesterday, manager Aaron Boone described the injury as “significant” while adding that they would still try to get more information. Today’s announcement of the elbow strain diagnosis will do little to quell fears about Green’s situation, as arm injuries are always concerning for a pitcher. However, it seems further testing is still forthcoming, with Lindsey Adler of The Athletic relaying word from manager Aaron Boone that medical opinions are still being collected.

Regardless of how long he’s ultimately sidelined, it’s an unfortunate development for both Green and the Yankees. The righty has somewhat quietly been one of the most effective and durable relievers in the game over the past few years. This is his first trip to the injured list since 2016, his debut season. His 326 relief innings pitched from 2016 to the present are bested by only 21 other pitchers in the league. He hasn’t just been taking mop-up duty either, as he has a 2.79 ERA out of the bullpen in his career, with a 32.8% strikeout rate and 5.9% walk rate, racking up 11 saves and 52 holds.

While this is no doubt a blow to the Yankees’ bullpen corps, it’s also very unfortunate for Green personally, as he is set to reach free agency at season’s end. After years of being healthy and productive, suffering a serious injury just months before heading into the open market is incredibly unlucky timing, to state the obvious. However, even in a worst-case scenario where Green is headed for significant surgery that will put him out of action for more than a year, he’d likely still garner interest on a back-loaded or incentive-laden contract, such as those recently signed by Ken Giles, Kirby Yates or Tommy Kahnle. Of course, both Green and the Yankees will be hoping to avoid such a scenario.

Yankees Notes: Green, Gil, Judge

By | at

2:55pm: Boone provided nebulous but worrisome updates on each of Green and Gil this afternoon (via Max Goodman and Laura Albanese of Newsday). Gil’s injury is “significant,” per Boone, who didn’t specify whether surgery may be on the table. The organization fears Green could also be facing a notable absence but is awaiting further tests.

12:04pm: Yankees reliever Chad Green left yesterday’s loss to the Orioles after just 11 pitches, and the team later announced he’d experienced some forearm discomfort (via Brendan Kuty of NJ.com). They’ll know more upon receiving the results of an MRI today, and Green conceded postgame that he’s “concerned about it to a certain extent” (quote via Erik Boland of Newsday). “Obviously, when you’re dealing with an arm injury, you’re not really sure what can happen or what’s really going on. We’ll get it checked out … and go from there.”

Even if the imaging results are good, it seems a precautionary injured list stint could be on the table. That’s unfamiliar territory for Green, who hasn’t landed on the IL since his 2016 season was cut short by a forearm tendon problem. The right-hander returned the following year seemingly no worse for wear, and he’s been one of the game’s predominant bullpen workhorses in the half-decade since then. Going back to the start of the 2017 season, only four relievers have taken on a heavier workload — and that’s not counting the 15 starts Green made in 2019.

He owns a sterling 2.87 ERA as a reliever over that stretch, striking out a lofty 33.1% of opposing hitters while showcasing atypically excellent control (5.9% walk rate) for a late-game arm. Skipper Aaron Boone has deployed Green as a high-leverage stopper throughout that run, often to great success. His strikeout and walk numbers haven’t been dominant over 15 frames this season, but Green owns a flat 3.00 ERA and a 14.5% swinging strike rate that isn’t far off his prior years’ marks.

More out of the Bronx:

  • New York is also dealing with some injury concerns at the minor league level. Prospect Luis Gil pulled himself from Wednesday night’s Triple-A start after experiencing an elbow injury (h/t to Joe McDonald of the Worcester Telegram and Gazette). Yesterday, Boone told reporters (including Bryan Hoch of MLB.com) that Gil was set for a visit with team physician Dr. Christopher Ahmad. As with Green, more information will be known upon further testing, but Gil is a key depth arm for the Yankees. The 23-year-old made his first six MLB starts last season, posting a 3.07 ERA across 29 1/3 innings. He hasn’t performed well thus far in 2022 with their top affiliate in Scranton/Wilkes-Barre, struggling with both walks and home runs en route to a 7.89 ERA over six starts. Nevertheless, Gil was called up for a spot start against the White Sox last week. He’s the only pitcher outside the primary five of Gerrit Cole, Nestor Cortes, Jordan Montgomery, Luis Severino and Jameson Taillon to start a game for New York this season.
  • In non-injury matters, Kiley McDaniel of ESPN takes a look at how Aaron Judge’s incredible start to the season could impact his free agent trajectory. Obviously, posting a .307/.381/.664 line through his first 36 games will help Judge’s market value, but there aren’t many clean comparison points for a player with his profile hitting the market in advance of his age-31 season. Judge famously rejected the Yankees’ seven-year, $213.5MM extension offer in Spring Training, and McDaniel feels he’d be in line to top $250MM if he continues to perform at a career-best pace. McDaniel also floats some possible landing spots if Judge were to leave the Bronx, hearing from rival executives who speculate that the Mets might relish the opportunity to make a run at the three-time All-Star.
Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

hide arrows scroll to top